Sponsors (5)
The bill improves detection and access to prevent congenital syphilis—potentially averting serious infant harm—at the cost of added short‑term burdens and implementation costs for states, providers, and underserved communities, and its impact depends on whether treatment capacity and uniform adoption keep pace with expanded screening.
Pregnant women and newborns will face a lower risk of congenital syphilis, stillbirth, and infant death because the bill promotes third‑trimester and delivery screening that enables earlier detection and treatment.
Low‑income pregnant women, Medicaid/CHIP enrollees, and American Indian/Alaska Native patients will gain increased access to syphilis screening through expanded Medicaid/CHIP and Indian health program guidance.
Non‑English speakers and rural patients (including tribal communities) will have improved access to education and care via telehealth integration and multilingual resources.
Pregnant women and prenatal clinics—especially in underserved and rural areas—may face short‑term strain as more positive diagnoses increase demand for treatment and follow‑up, potentially exceeding local capacity.
State governments, Medicaid/CHIP programs, and taxpayers may incur significant additional costs to change screening, telehealth, and reporting practices required to implement the bill.
Hospitals, clinics, and healthcare workers will face operational burdens and training costs to implement new third‑trimester/delivery testing and multilingual telehealth services.
Based on analysis of 3 sections of legislative text.
Requires HHS to issue guidance (within 12 months) and a report (within 2 years) to expand syphilis screening, treatment, telehealth, and education—especially third‑trimester/delivery testing—using Medicaid/CHIP authorities.
Introduced June 10, 2025 by Juan Ciscomani · Last progress June 10, 2025
Directs the HHS Secretary to issue federal guidance within 12 months to State Medicaid and CHIP agencies, the Indian Health Service, tribal entities, and Urban Indian organizations on expanding syphilis screening, education, telehealth access (including interpreter and multilingual resources), third‑trimester and delivery testing, and improved treatment for syphilis and congenital syphilis. Requires a public report to specified congressional committees within two years analyzing implementation of those best practices and use of Medicaid/CHIP authorities (including section 1115 waivers and titles XIX and XXI).